MBD2 and myeloid leukemia: Recipient mice from both the Mbd2−/− group and the WT group developed AML, and the GFP+ cells were shown to be B220−CD3−Mac-1+ by flow cytometric analysis, suggesting the construction of a myeloid leukemia model (Supplementary Fig. S2D).